Page last updated: 2024-08-24

lamivudine and inosine pranobex

lamivudine has been researched along with inosine pranobex in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aydin, OF; Gürer, YK; Kuyucu, N; Senbil, N	1
Anlar, B	1
Antonov, K; Jelev, DT; Krastev, Z	1

Trials

1 trial(s) available for lamivudine and inosine pranobex

Article	Year
Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis. Journal of child neurology, 2003, Volume: 18, Issue:2 Topics: Administration, Oral; Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Subcutaneous; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Patient Compliance; Recombinant Proteins; Reverse Transcriptase Inhibitors; Subacute Sclerosing Panencephalitis; Survival; Treatment Outcome	2003

Article

Year

Combined treatment with subcutaneous interferon-alpha, oral isoprinosine, and lamivudine for subacute sclerosing panencephalitis.

Journal of child neurology, 2003, Volume: 18, Issue:2

Topics: Administration, Oral; Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Injections, Subcutaneous; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Patient Compliance; Recombinant Proteins; Reverse Transcriptase Inhibitors; Subacute Sclerosing Panencephalitis; Survival; Treatment Outcome

2003

Other Studies

2 other study(ies) available for lamivudine and inosine pranobex

Article	Year
Preliminary results for treatments in subacute sclerosing panencephalitis have problems? Journal of child neurology, 2004, Volume: 19, Issue:6 Topics: Antiviral Agents; Clinical Trials as Topic; Drug Costs; Humans; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Recombinant Proteins; Reproducibility of Results; Reverse Transcriptase Inhibitors; Subacute Sclerosing Panencephalitis; Treatment Outcome	2004
The prevention of an expected hepatic flare in HBe negative patients after lamivudine discontinuation. Journal of gastrointestinal and liver diseases : JGLD, 2006, Volume: 15, Issue:4 Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Secondary Prevention; Time Factors; Treatment Outcome; Viral Load	2006

Article

Year

Preliminary results for treatments in subacute sclerosing panencephalitis have problems?

Journal of child neurology, 2004, Volume: 19, Issue:6

Topics: Antiviral Agents; Clinical Trials as Topic; Drug Costs; Humans; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Recombinant Proteins; Reproducibility of Results; Reverse Transcriptase Inhibitors; Subacute Sclerosing Panencephalitis; Treatment Outcome

2004

The prevention of an expected hepatic flare in HBe negative patients after lamivudine discontinuation.

Journal of gastrointestinal and liver diseases : JGLD, 2006, Volume: 15, Issue:4

Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inosine Pranobex; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Secondary Prevention; Time Factors; Treatment Outcome; Viral Load

2006